Leif Gunnar Håkansson
Director Ejecutivo en CanImGuide Therapeutics AB .
Perfil
Leif Gunnar Håkansson is the founder of CanImGuide Therapeutics AB.
Prior to founding the company, he worked as the Head of Clinical Tumor Immunology Division at the University of Linköping and as an Associate Professor at the University of Lund.
He holds a doctorate degree from the University of Lund.
Cargos activos de Leif Gunnar Håkansson
| Empresas | Cargo | Inicio |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director Ejecutivo | - |
Antiguos cargos conocidos de Leif Gunnar Håkansson.
| Empresas | Cargo | Fin |
|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - |
| University of Lund | Corporate Officer/Principal | - |
Formación de Leif Gunnar Håkansson.
| University of Lund | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Leif Gunnar Håkansson
